Faster global financial news!
GlaxoSmithKline
-
GSK to leverage patient data from Greater Bay Area's 88 million residents to accelerate vaccine and cancer drug development
GSK to leverage patient data from Greater Bay Area's 88 million residents to accelerate vaccine and cancer drug development
-
Hong Kong to unveil first five-year plan next week, targeting biomedicine powerhouse status; GSK expresses interest in region's biotech development on Wednesday
Hong Kong's inaugural five-year plan, set to be unveiled next week, will focus on establishing the city as a biomedicine powerhouse, signaling closer medical cooperation across the Greater Bay Area. G
-
Citi maintains 'neutral' rating on GSK, lifts earnings forecasts as shares rise 0.31%, citing unproven Phase III pipeline and Jemperli litigation as long-term growth concerns
Citi adjusted its model after GSK's Accelerate Growth event and Q2 results. The investment bank noted GSK's £1.9 billion cost-savings drive will fund 20 Phase III trials in 2026, which Citi expects to
-
GSK to leverage patient data from Greater Bay Area's 88 million residents to accelerate vaccine and cancer drug development
GSK to leverage patient data from Greater Bay Area's 88 million residents to accelerate vaccine and cancer drug development
-
Hong Kong to unveil first five-year plan next week, targeting biomedicine powerhouse status; GSK expresses interest in region's biotech development on Wednesday
Hong Kong's inaugural five-year plan, set to be unveiled next week, will focus on establishing the city as a biomedicine powerhouse, signaling closer medical cooperation across the Greater Bay Area. G
-
Citi maintains 'neutral' rating on GSK, lifts earnings forecasts as shares rise 0.31%, citing unproven Phase III pipeline and Jemperli litigation as long-term growth concerns
Citi adjusted its model after GSK's Accelerate Growth event and Q2 results. The investment bank noted GSK's £1.9 billion cost-savings drive will fund 20 Phase III trials in 2026, which Citi expects to
- No data
GlaxoSmithKline
24H Trending
-
1
BitMart Exchange API Key Creation Guide and Security Recommendations
-
2
CHAMP Token Trading Guide: Multi-Project Analysis and Exchange Overview
-
3
AFIN Coin: Exploring Its Connection to Cryptocurrency and Sustainable Development, and Its Future Prospects
-
4
CSM Coin Analysis: The Current Status and Development of Crust Shadow and its Token
-
5
Global Major Cryptocurrency Platform Withdrawal Guide and Market Landscape Analysis
-
6
Iraq's state tanker company arranges VLCC to transport 2 million barrels of crude beyond Strait of Hormuz, shifting oil strategy to offer oil outside Persian Gulf
-
7
Bank of America warns: The AI narrative is acting as a "buffer" against macro risks, and its failure could trigger a market-wide crisis.
-
8
EPFR data shows: Bonds saw net inflows of $18.8 billion, with long-term bond inflows reaching their largest since May 2025.
-
9
Chinese AI micro-drama producers face audience fatigue, NetEase uses AI to recreate Joey Wong's classic roles.
-
10
What is DDR Coin? An Analysis of DigiDinar (DDR) Cryptocurrency's Current Status and Multiple Meanings
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
